Antiparasitic treatment for severe imported malaria in metropolitan France
uses antimalarial schizonticides, active against Plasmodium falciparum chlo
roquine-resistant strains. Quinine, still very efficient, is the basis of t
his treatment. Its pharmacokinetic and pharmacodynamic properties have been
largely studied. Its neurosensorial and cardiovascular toxicity has been w
ell demonstrated. Artemether can be an interesting alternative when confron
ted with polychemoresistant strains. Neurotoxicity was demonstrated in anim
al models. Antiparasitic treatment is usually quinine IV. There are differe
nces in doses, therapeutic protocols, and maximum dosage. There is a contro
versy over whether or not to use a loading dose. The treatment surveillance
mode is not well defined. Antibiotics and artemether can be used for speci
fic indications. (C) 1999 Editions scientifiques et medicales Elsevier SAS.